Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YNL183C | NPR1 | SGDID:S000005127 | AAK1 KIAA1048 |
AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) |
2.7.11.1 | Homo sapiens | Parkinson Disease, Late-Onset,Cataract 8, Multiple Types,Hepatitis C Virus,Rabies |
5te0_a | Q2M2I8 | ENSG00000115977 | AAK1 | 99.40 | 2.80E-17 | 3.50E-21 | 158.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CASK LIN2 |
Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog) |
2.7.11.1 | Homo sapiens | Cask-Related Disorders,Cerebellar Hypoplasia,Constipation,Congenital Nystagmus,Pathologic Nystagmus,Neurofibromatosis, Type I,Fraser Syndrome 1,Cask Disorders,Cerebellar Disease,Dystonia,Glucosephosphate Dehydrogenase Deficiency,Lobular Neoplasia,X-Linked Intellectual Disability, Najm Type,Cask-Related Intellectual Disability,Microcephaly,Hypertonia,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Fg Syndrome 4,Helsmoortel-Van Der Aa Syndrome,Aland Island Eye Disease,Developmental And Epileptic Encephalopathy 8,Mental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia,Anemia, Nonspherocytic Hemolytic, Due To G6pd Deficiency,Coffin-Siris Syndrome 1,Early Infantile Epileptic Encephalopathy,Opitz-Kaveggia Syndrome,Pontocerebellar Hypoplasia,Autism,Cerebellar Hypoplasia/Atrophy, Epilepsy, And Global Developmental Delay,Peho Syndrome |
3c0g_b | O14936 | ENSG00000147044 | CASK | 99.50 | 4.60E-19 | 5.60E-23 | 174.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CAMKK1 CAMKKA |
Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha) |
2.7.11.17 | Homo sapiens | Tracheitis |
6ccf_b | Q8N5S9 | ENSG00000004660 | CAMKK1 | 99.30 | 5.60E-17 | 7.40E-21 | 148.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | STK10 LOK |
Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) |
2.7.11.1 | Homo sapiens | Testicular Germ Cell Tumor |
4bc6_a | O94804 | ENSG00000072786 | STK10 | 99.40 | 2.50E-17 | 3.20E-21 | 153.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MKNK2 GPRK7 MNK2 |
MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) |
2.7.11.1 | Homo sapiens | 2ac3_a | Q9HBH9 | ENSG00000099875 | MKNK2 | 99.40 | 2.80E-17 | 3.60E-21 | 154.50 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | PRKACA PKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Homo sapiens | Mixed Fibrolamellar Hepatocellular Carcinoma,Fibrolamellar Carcinoma,Cardioacrofacial Dysplasia 1,Dilated Cardiomyopathy,Acth-Independent Cushing Syndrome,Osteoporosis,Breast Cancer,Pigmented Nodular Adrenocortical Disease, Primary, 4,Primary Pigmented Nodular Adrenocortical Disease |
4wb8_a | P17612 | ENSG00000072062 | PRKACA | 99.30 | 6.10E-17 | 7.60E-21 | 155.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MAP3K8 COT ESTF |
Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25) (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2) (TPL-2) |
2.7.11.25 | Homo sapiens | Indolent Plasma Cell Myeloma,Paronychia,Skin Lipoma,Rheumatoid Arthritis,Lung Cancer |
4y85_b | P41279 | ENSG00000107968 | MAP3K8 | 99.50 | 1.80E-18 | 2.20E-22 | 166.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CSNK2A1 CK2A1 |
Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Okur-Chung Neurodevelopmental Syndrome,Connective Tissue Disease,Alzheimer Disease,Prostate Stromal Sarcoma,Distal Muscular Dystrophy With Anterior Tibial Onset,Kidney Leiomyosarcoma,Colorectal Cancer,Microcephaly,Alacrima, Achalasia, And Mental Retardation Syndrome,Prostate Cancer,Disease Of Mental Health,Malaria |
3q04_a | P68400 | ENSG00000101266 | CSNK2A1 | 99.30 | 4.80E-17 | 6.10E-21 | 154.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | STK3 KRS1 MST2 |
Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] |
2.7.11.1 | Homo sapiens | Non-Syndromic X-Linked Intellectual Disability |
4lg4_a | Q13188 | ENSG00000104375 | STK3 | 99.40 | 1.50E-17 | 1.90E-21 | 156.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MELK KIAA0175 |
Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) |
2.7.10.2 | Homo sapiens | Colorectal Cancer |
5k00_a | Q14680 | ENSG00000165304 | MELK | 99.40 | 1.40E-17 | 1.70E-21 | 162.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | GL50803_008037 GL50803_8037 |
GL50803_008037 GL50803_8037 |
Giardia intestinalis | 3gbz_a | A8BZ95 | 99.30 | 5.90E-17 | 7.40E-21 | 155.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | aurkb-a airk2-a |
Aurora kinase B-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 2-A) (AIRK2-A) (XAIRK2-A) (Serine/threonine-protein kinase 12-A) (Serine/threonine-protein kinase aurora-B-A) (xAurora-B) |
2.7.11.1 | Xenopus laevis | 4c2v_b | Q6DE08 | 99.40 | 3.40E-17 | 4.40E-21 | 151.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | BIK1 At2g39660 F12L6.32 F17A14.3 |
Serine/threonine-protein kinase BIK1 (EC 2.7.11.1) (Protein BOTRYTIS-INDUCED KINASE 1) |
2.7.11.1 | Arabidopsis thaliana | 5tos_a | O48814 | 99.40 | 4.60E-18 | 5.60E-22 | 168.80 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | PASK KIAA0135 |
PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Niemann-Pick Disease, Type C1 |
3dls_a | Q96RG2 | ENSG00000115687 | PASK | 99.40 | 1.90E-17 | 2.30E-21 | 160.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ABL1 ABL JTK7 |
Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) |
2.7.10.2 | Homo sapiens | Heart Disease,Childhood Acute Lymphocytic Leukemia,Childhood T-Cell Acute Lymphoblastic Leukemia,Myeloid And Lymphoid Neoplasms Associated With Pdgfra Rearrangement,Chronic Neutrophilic Leukemia,Melanoma,Chronic Eosinophilic Leukemia,Leukemia, Chronic Myeloid,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma With Bcr-Abl1,B-Lymphoblastic Leukemia/Lymphoma With Hypodiploidy,B-Lymphoblastic Leukemia/Lymphoma, Bcr-Abl1-Like,B-Lymphoblastic Leukemia/Lymphoma With Iamp21,Lung Large Cell Carcinoma,Blood Platelet Disease,Essential Thrombocythemia,Myeloproliferative Neoplasm,Testicular Leukemia,Philadelphia-Negative Chronic Myeloid Leukemia,Leukemia,Mixed Phenotype Acute Leukemia,Myelophthisic Anemia,Blood Coagulation Disease,Hypereosinophilic Syndrome,Childhood Leukemia,Leukemia, Acute Myeloid,Bone Marrow Cancer,Myelodysplastic/Myeloproliferative Neoplasm,Hematologic Cancer,Leukemia, Acute Lymphoblastic,Moyamoya Angiopathy,Polycythemia,Leiomyomatosis,Central Nervous System Leukemia,Precursor T-Cell Acute Lymphoblastic Leukemia,Acquired Polycythemia,T-Cell Prolymphocytic Leukemia,Chronic Leukemia,Cockayne Syndrome,Prolymphocytic Leukemia,Lip And Oral Cavity Cancer,Ovarian Cancer,Myeloid Leukemia,T-Cell Acute Lymphoblastic Leukemia,Adult Acute Lymphocytic Leukemia,Breast Cancer,Colorectal Cancer,Congenital Heart Defects And Skeletal Malformations Syndrome,Deficiency Anemia,Leukemia, Acute Lymphoblastic 3,Retinoblastoma,Mental Retardation, Autosomal Dominant 29,Myelodysplastic Syndrome,Mental Retardation, Autosomal Dominant 33,Gastrointestinal Stromal Tumor,Lymphoblastic Leukemia, Acute, With Lymphomatous Features,Wilms Tumor 1,Leukemia, Chronic Lymphocytic,Dermatofibrosarcoma Protuberans,Ataxia-Telangiectasia,B-Cell Adult Acute Lymphocytic Leukemia,Atypical Chronic Myeloid Leukemia,Polycythemia Vera |
5hu9_a | P00519 | ENSG00000097007 | ABL1 | 99.30 | 7.20E-17 | 9.30E-21 | 148.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | EIF2AK3 PEK PERK |
Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK) |
2.7.11.1 | Homo sapiens | Skin Melanoma,Retinitis Pigmentosa,Neonatal Diabetes,Prion Disease,Diabetes Mellitus,Alzheimer Disease,Rasopathy,Retinal Degeneration,Subungual Glomus Tumor,Crisponi/Cold-Induced Sweating Syndrome 1,Osteoporosis,Wolfram Syndrome,Epiphyseal Dysplasia, Multiple, With Early-Onset Diabetes Mellitus,Disease Of Mental Health,Leukoencephalopathy With Vanishing White Matter,Odontochondrodysplasia,Trichothiodystrophy 5, Nonphotosensitive,Cardiomyopathy, Familial Hypertrophic, 25,Permanent Neonatal Diabetes Mellitus,Palmoplantar Keratoderma, Bothnian Type |
4g31_a | Q9NZJ5 | ENSG00000172071 | EIF2AK3 | 99.30 | 4.70E-17 | 6.20E-21 | 150.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDK2 CDKN2 |
Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) |
2.7.11.22 | Homo sapiens | Pancreatic Adenocarcinoma,Endometrial Cancer,Smooth Muscle Tumor,Melanoma,Endometrial Hyperplasia,Leukemia, Chronic Myeloid,Leiomyosarcoma,Ocular Cancer,Retinal Cancer,Neuroblastoma,Leukemia, Acute Myeloid,Leukemia, Acute Lymphoblastic,Bladder Cancer,Lung Adenoma,Laryngeal Squamous Cell Carcinoma,Ovarian Cancer,Testicular Cancer,Eye Disease,Uterine Sarcoma,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Colorectal Cancer,Nervous System Cancer,Hepatocellular Carcinoma,Microcephaly,Pheochromocytoma,Skin Carcinoma,Gastric Cancer,Prostate Cancer,Cervical Cancer,Cecal Benign Neoplasm,Retinoblastoma,Sensory System Disease,Trichothiodystrophy 5, Nonphotosensitive,Mantle Cell Lymphoma,Gastrointestinal Stromal Tumor,Cecum Adenoma,Leukemia, Chronic Lymphocytic,Ataxia-Telangiectasia,Melanoma, Cutaneous Malignant 1,Lung Cancer,Pancreatic Cancer |
4i3z_c | P24941 | ENSG00000123374 | CDK2 | 99.40 | 1.10E-17 | 1.40E-21 | 155.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDK9 CDC2L4 TAK |
Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) |
2.7.11.22,2.7.11.23, | Homo sapiens | Leukemia, Acute Myeloid,Human Immunodeficiency Virus Type 1,Immune Deficiency Disease,Leukemia, Chronic Lymphocytic,Nut Midline Carcinoma |
3mi9_a | P50750 | ENSG00000136807 | CDK9 | 99.40 | 4.70E-17 | 5.80E-21 | 158.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | SKY1 YMR216C YM8261.10C |
Serine/threonine-protein kinase SKY1 (SRPK) (EC 2.7.11.1) |
2.7.11.1 | Saccharomyces cerevisiae | 1q8y_b | Q03656 | 99.30 | 1.10E-16 | 1.30E-20 | 156.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | ROP 2 |
ROP 2 |
Toxoplasma gondii | 2w1z_b | Q27007 | 99.40 | 3.40E-17 | 4.30E-21 | 158.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 |
Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) |
2.7.12.2 | Homo sapiens | Cardiomyopathy, Familial Hypertrophic, 25,Primary Autosomal Recessive Microcephaly |
5y90_a | O14733 | ENSG00000076984 | MAP2K7 | 99.40 | 3.30E-17 | 4.10E-21 | 156.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDKL3 NKIAMRE |
Cyclin-dependent kinase-like 3 (EC 2.7.11.22) (Serine/threonine-protein kinase NKIAMRE) |
2.7.11.22 | Homo sapiens | Orofaciodigital Syndrome Vi |
3zdu_a | Q8IVW4 | ENSG00000006837 | CDKL3 | 99.40 | 3.40E-17 | 4.30E-21 | 156.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDKL5 STK9 |
Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9) |
2.7.11.22 | Homo sapiens | Cdkl5 Deficiency Disorder,Ohtahara Syndrome,Seizure Disorder,Childhood Absence Epilepsy,Epilepsy,Gait Apraxia,Gene Duplication Disease,Nicolaides-Baraitser Syndrome,Amyotrophic Lateral Sclerosis 1,Angelman Syndrome,Focal Epilepsy,Developmental And Epileptic Encephalopathy 14,Epilepsy With Generalized Tonic-Clonic Seizures,Congenital Nervous System Abnormality,Developmental And Epileptic Encephalopathy,Fundus Dystrophy,Juvenile Retinoschisis,Bruxism,X-Linked Congenital Retinoschisis,Early Myoclonic Encephalopathy,Stxbp1 Encephalopathy,Microcephaly,Mental Retardation, Autosomal Dominant 20,Encephalopathy,Benign Neonatal Seizures,Alacrima, Achalasia, And Mental Retardation Syndrome,Benign Epilepsy With Centrotemporal Spikes,Developmental And Epileptic Encephalopathy 9,Methylmalonic Acidemia,Benign Familial Neonatal Epilepsy,West Syndrome,Disease Of Mental Health,Lubs X-Linked Mental Retardation Syndrome,Fragile X Syndrome,Pitt-Hopkins Syndrome,Mowat-Wilson Syndrome,Developmental And Epileptic Encephalopathy 2,Lennox-Gastaut Syndrome,Sturge-Weber Syndrome,Neonatal Period Electroclinical Syndrome,Infancy Electroclinical Syndrome,Childhood Electroclinical Syndrome,Early Infantile Epileptic Encephalopathy,Developmental And Epileptic Encephalopathy 4,Myasthenic Syndrome, Congenital, 11, Associated With Acetylcholine Receptor Deficiency,Encephalopathy Due To Defective Mitochondrial And Peroxisomal Fission 1,Aicardi Syndrome,Specific Developmental Disorder,Pervasive Developmental Disorder,Dravet Syndrome,Developmental And Epileptic Encephalopathy 1,Benign Familial Infantile Epilepsy,Generalized Epilepsy With Febrile Seizures Plus,Pyruvate Dehydrogenase E1-Alpha Deficiency,Retinoschisis 1, X-Linked, Juvenile,Rett Syndrome,Epilepsy, Myoclonic Juvenile,Autism,Christianson Syndrome,Epilepsy, Idiopathic Generalized,Peho Syndrome |
4bgq_a | O76039 | ENSG00000008086 | CDKL5 | 99.50 | 1.50E-18 | 2.00E-22 | 160.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | Ripk4 Ankrd3 Pkk |
Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-associated protein kinase) (PKC-regulated protein kinase) |
2.7.11.1 | Mus musculus | 5wnj_a | Q9ERK0 | 99.40 | 3.20E-17 | 3.90E-21 | 158.70 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | FUS3 DAC2 YBL016W YBL03.21 YBL0303 |
Mitogen-activated protein kinase FUS3 (MAP kinase FUS3) (EC 2.7.11.24) |
2.7.11.24 | Saccharomyces cerevisiae | 2b9h_a | P16892 | 99.30 | 6.90E-17 | 8.50E-21 | 157.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | IRE1 ERN1 YHR079C |
Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)] |
2.7.11.1 | Saccharomyces cerevisiae | 3sdj_k | P32361 | 99.30 | 1.10E-16 | 1.30E-20 | 163.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | EPHB4 HTK MYK1 TYRO11 |
Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) |
2.7.10.1 | Homo sapiens | Endometrial Cancer,Liver Carcinoma In Situ,Capillary Malformation-Arteriovenous Malformation 1,Skin Angiosarcoma,Parkes Weber Syndrome,Brain Stem Astrocytic Neoplasm,Hereditary Hemorrhagic Telangiectasia,Lymphatic Malformation 7,Ovarian Cancer,Breast Cancer,Squamous Cell Carcinoma, Head And Neck,Weber Syndrome,Colorectal Cancer,Arteriovenous Malformation,Microvascular Complications Of Diabetes 1,Capillary Malformation-Arteriovenous Malformation 2,Tetralogy Of Fallot,Cardiovascular Organ Benign Neoplasm,Hennekam Syndrome |
6fnk_a | P54760 | ENSG00000196411 | EPHB4 | 99.30 | 9.70E-17 | 1.30E-20 | 149.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PAK1 |
Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK) |
2.7.11.1 | Homo sapiens | Thymic Neuroendocrine Tumor,Prolapse Of Urethra,Gastroesophageal Junction Adenocarcinoma,Neurofibromatosis,Breast Cancer,Colorectal Cancer,Gastric Cancer,Intellectual Developmental Disorder With Macrocephaly, Seizures, And Speech Delay,Helicobacter Pylori Infection |
5kbq_a | Q13153 | ENSG00000149269 | PAK1 | 99.40 | 2.30E-17 | 2.90E-21 | 153.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PRKG1 PRKG1B PRKGR1A PRKGR1B |
cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) |
2.7.11.12 | Homo sapiens | Myopathy,Impotence,Connective Tissue Disease,Diabetes Mellitus,Aortic Dissection,Alzheimer Disease,Familial Thoracic Aortic Aneurysm And Aortic Dissection,Cystic Fibrosis,Aortic Disease,Aortic Valve Disease 1,Heritable Thoracic Aortic Disease,Hemolytic Anemia,Non-Proliferative Fibrocystic Change Of The Breast,Aneurysm,Aortic Aneurysm, Familial Thoracic 8,Disease Of Mental Health,Pulmonary Hypertension,Body Mass Index Quantitative Trait Locus 11,Aortic Aneurysm,Loeys-Dietz Syndrome,Immune Deficiency Disease,Myelodysplastic Syndrome,Attention Deficit-Hyperactivity Disorder,Aortic Aneurysm, Familial Thoracic 1,Hypertension, Essential,Sexual Disorder |
6bg2_a | Q13976 | ENSG00000185532 | PRKG1 | 99.40 | 2.60E-17 | 3.20E-21 | 160.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | cgd2_1960 |
cgd2_1960 |
2.7.11.24 | Cryptosporidium parvum | 3oz6_a | A3FQ79 | 99.40 | 1.80E-17 | 2.20E-21 | 162.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | cgd7_40 |
cgd7_40 |
Cryptosporidium parvum | 3hko_a | Q5CZ29 | 99.40 | 1.50E-17 | 1.80E-21 | 162.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | CPK2 CDPK2 |
Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2) |
2.7.11.1 | Plasmodium falciparum | 4mvf_a | O15865 | 99.40 | 3.30E-17 | 4.10E-21 | 166.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | SRK2E OST1 SNRK2.6 At4g33950 F17I5.140 |
Serine/threonine-protein kinase SRK2E (EC 2.7.11.1) (Protein OPEN STOMATA 1) (SNF1-related kinase 2.6) (SnRK2.6) (Serine/threonine-protein kinase OST1) |
2.7.11.1 | Arabidopsis thaliana | 3udb_d | Q940H6 | 99.30 | 1.10E-16 | 1.30E-20 | 153.30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Bos taurus | 2uzv_a | P00517 | 99.30 | 1.10E-16 | 1.30E-20 | 154.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | CDK12 CRK7 CRKRS KIAA0904 |
Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) |
2.7.11.22,2.7.11.23, | Homo sapiens | Lung Cancer Susceptibility 3,Bartholin'S Gland Adenocarcinoma,Corneal Endothelial Dystrophy,Gastric Cancer,Lung Cancer |
4cxa_c | Q9NYV4 | ENSG00000167258 | CDK12 | 99.40 | 2.80E-17 | 3.60E-21 | 158.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | JAK1 JAK1A JAK1B |
Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1) |
2.7.10.2 | Homo sapiens | Psoriasis,Breast Implant-Associated Anaplastic Large Cell Lymphoma,Endometrial Cancer,Severe Combined Immunodeficiency,Hepatitis C,Covid-19,Blood Platelet Disease,Hepatitis,Leukemia,Blood Coagulation Disease,Wernicke Encephalopathy,Leukemia, Acute Myeloid,Sting-Associated Vasculopathy With Onset In Infancy,Bone Marrow Cancer,Leukemia, Acute Lymphoblastic,Combined Immunodeficiency,Polycythemia,Autosomal Recessive Mendelian Susceptibility To Mycobacterial Diseases Due To Partial Jak1 Deficiency,Crisponi/Cold-Induced Sweating Syndrome 1,Colonic Disease,Acute Megakaryoblastic Leukemia In Down Syndrome,Herpes Zoster,Autoimmune Lymphoproliferative Syndrome,T-Cell Prolymphocytic Leukemia,Mixed Lacrimal Gland Cancer,Prolymphocytic Leukemia,Nasopharyngitis,Ovarian Cancer,T-Cell Acute Lymphoblastic Leukemia,Acute Megakaryocytic Leukemia,Breast Cancer,Colorectal Cancer,Hepatocellular Carcinoma,Jak3-Deficient Severe Combined Immunodeficiency,Fibrosarcoma,Prostate Cancer,Chilblain Lupus 1,Severe Combined Immunodeficiency, X-Linked,Mouth Disease,Immunodeficiency 27b,Immunodeficiency 35,Aicardi-Goutieres Syndrome,Down Syndrome,Acute Promyelocytic Leukemia,Lymphoblastic Leukemia, Acute, With Lymphomatous Features,Leukemia, Acute, X-Linked,Alopecia Universalis Congenita,Autoinflammation, Immune Dysregulation, And Eosinophilia,Systemic Lupus Erythematosus,Myelofibrosis,Lymphoproliferative Syndrome,Immunodeficiency 27a,Pancreatic Cancer,Polycythemia Vera |
3eyh_a | P23458 | ENSG00000162434 | JAK1 | 99.30 | 8.00E-17 | 1.10E-20 | 147.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | GSK3B |
Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) |
2.7.11.26 | Homo sapiens | Liver Disease,Endometrial Cancer,Epilepsy,Polycystic Kidney Disease,Diabetes Mellitus,Alzheimer Disease,Major Depressive Disorder,Neuroblastoma,Cervical Non-Keratinizing Squamous Cell Carcinoma,Barbiturate Dependence,Alzheimer Disease 9,Dementia,Fallopian Tube Serous Adenocarcinoma,Breast Cancer,Parkinson Disease, Late-Onset,Colorectal Cancer,Parkinson Disease 1, Autosomal Dominant,Hepatocellular Carcinoma,Bipolar Disorder,Gastric Cancer,Prostate Cancer,Disease Of Mental Health,Type 2 Diabetes Mellitus,Schizophrenia,Ophthalmomyiasis,Familial Adenomatous Polyposis,Severe Congenital Neutropenia,Aneurysmal Bone Cysts,Attention Deficit-Hyperactivity Disorder,Medulloblastoma,Frontotemporal Dementia,Pancreatic Cancer |
1j1b_b | P49841 | ENSG00000082701 | GSK3B | 99.50 | 2.60E-18 | 3.20E-22 | 171.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ROR2 NTRKR2 |
Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2) |
2.7.10.1 | Homo sapiens | Robinow Syndrome, Autosomal Recessive 1,Autosomal Dominant Robinow Syndrome,Basal Cell Nevus Syndrome,Brachydactyly, Type A1,Ror2-Related Robinow Syndrome,Brachydactyly, Type B1,Fallopian Tube Serous Adenocarcinoma,Breast Cancer,Polydactyly,Robinow Syndrome, Autosomal Dominant 1,Brachydactyly,Distal Arthrogryposis,Proximal Symphalangism,Robinow Syndrome,Omodysplasia,Fetal Akinesia Deformation Sequence 1 |
3zzw_a | Q01974 | ENSG00000169071 | ROR2 | 99.30 | 5.30E-17 | 7.20E-21 | 147.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MAPK6 ERK3 PRKM6 |
Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3) (MAP kinase isoform p97) (p97-MAPK) |
2.7.11.24 | Homo sapiens | Pulmonary Immaturity,Aromatase Excess Syndrome |
2i6l_a | Q16659 | ENSG00000069956 | MAPK6 | 99.40 | 1.40E-17 | 1.90E-21 | 156.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ROP5C |
ROP5C |
Toxoplasma gondii | 4lv8_a | I6ZQR7 | 99.30 | 7.90E-17 | 1.00E-20 | 156.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | CPK4 CDPK4 PF07_0072 |
Calcium-dependent protein kinase 4 (EC 2.7.11.1) |
2.7.11.1 | Plasmodium falciparum | 4rgj_a | Q8IBS5 | 99.40 | 1.60E-17 | 2.00E-21 | 167.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | ERN1 IRE1 |
Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)] |
2.7.11.1 | Homo sapiens | Retinitis Pigmentosa,Non-Alcoholic Fatty Liver Disease,Prion Disease,Alzheimer Disease,Ovarian Cancer,Wolfram Syndrome,Epiphyseal Dysplasia, Multiple, With Early-Onset Diabetes Mellitus,Huntington Disease |
6hx1_a | O75460 | ENSG00000178607 | ERN1 | 99.30 | 8.70E-17 | 1.00E-20 | 161.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MAP3K5 ASK1 MAPKKK5 MEKK5 |
Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) |
2.7.11.25 | Homo sapiens | Liver Disease,Non-Alcoholic Fatty Liver Disease,Pyriform Sinus Cancer,Fatty Liver Disease,Alzheimer Disease,Glottis Squamous Cell Carcinoma,Partial Third-Nerve Palsy,Neural Tube Defects,Huntington Disease |
5uox_a | Q99683 | ENSG00000197442 | MAP3K5 | 99.40 | 2.20E-17 | 2.90E-21 | 150.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PIM1 |
Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Retinitis Pigmentosa,Polyploidy,Plasma Protein Metabolism Disease,Primary Central Nervous System Lymphoma,Diamond-Blackfan Anemia,Myeloid Leukemia,Prostate Cancer,Mantle Cell Lymphoma |
1xr1_a | P11309 | ENSG00000137193 | PIM1 | 99.30 | 5.10E-17 | 6.60E-21 | 152.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | Stk39 Spak |
STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (Serine/threonine-protein kinase 39) |
2.7.11.1 | Mus musculus | 5dbx_a | Q9Z1W9 | 99.40 | 3.60E-17 | 4.50E-21 | 156.00 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | EPHA3 ETK ETK1 HEK TYRO4 |
Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1) |
2.7.10.1 | Homo sapiens | Large Cell Carcinoma,Lung Large Cell Carcinoma,Cerebral Artery Occlusion,Adenocarcinoma,Breast Cancer,Beriberi,Parkinson Disease, Late-Onset,Colorectal Cancer,Thiamine Deficiency Disease,Tumoral Calcinosis, Hyperphosphatemic, Familial, 1,Wet Beriberi |
2qoc_a | P29320 | ENSG00000044524 | EPHA3 | 99.30 | 9.70E-17 | 1.20E-20 | 154.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MAPK10 JNK3 JNK3A PRKM10 SAPK1B |
Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) |
2.7.11.24 | Homo sapiens | Cryptococcal Meningitis,Diabetes Mellitus,Alzheimer Disease,Amyotrophic Lateral Sclerosis 1,Cataract,Breast Cancer,Parkinson Disease, Late-Onset,Human Immunodeficiency Virus Type 1,Pheochromocytoma,Pertussis,Opioid Abuse,Type 2 Diabetes Mellitus,Lennox-Gastaut Syndrome,Huntington Disease,Pancreatic Cancer |
3oy1_a | P53779 | ENSG00000109339 | MAPK10 | 99.40 | 3.50E-17 | 4.30E-21 | 160.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | STK4 KRS2 MST1 |
Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] |
2.7.11.1 | Homo sapiens | T-Cell Immunodeficiency, Recurrent Infections, And Autoimmunity With Or Without Cardiac Malformations,Myeloproliferative Syndrome, Transient,Lymphoproliferative Syndrome 2,Epidermodysplasia Verruciformis 1,Immunodeficiency 13,Prostate Cancer,Coronin-1a Deficiency,Wilson-Turner X-Linked Mental Retardation Syndrome,Lung Cancer |
3com_a | Q13043 | ENSG00000101109 | STK4 | 99.30 | 7.80E-17 | 9.80E-21 | 153.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | DYRK1A DYRK MNB MNBH |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB) |
2.7.12.1 | Homo sapiens | Chromosomal Disease,Seizure Disorder,Alzheimer Disease,Myeloproliferative Syndrome, Transient,Distal Muscular Dystrophy With Anterior Tibial Onset,Congenital Nervous System Abnormality,Dyrk1a Syndrome,Acute Megakaryocytic Leukemia,Dyrk1a-Related Intellectual Disability Syndrome Due To 21q22.13q22.2 Microdeletion,Microphthalmia,Parkinson Disease, Late-Onset,Non-Specific Syndromic Intellectual Disability,Microcephaly,Intellectual Disability Syndrome Due To A Dyrk1a Point Mutation,Pick Disease Of Brain,Alacrima, Achalasia, And Mental Retardation Syndrome,Enophthalmos,Disease Of Mental Health,Mental Retardation, Autosomal Dominant 7,Down Syndrome,Syndromic Intellectual Disability,Specific Developmental Disorder,Autosomal Dominant Non-Syndromic Intellectual Disability,Chromosomal Duplication Syndrome,Autism,Primary Microcephaly |
4yu2_a | Q13627 | ENSG00000157540 | DYRK1A | 99.40 | 4.10E-17 | 5.10E-21 | 158.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | TCM_042446 |
TCM_042446 |
Theobroma cacao | 6cth_a | A0A061FLD4 | 99.30 | 1.00E-16 | 1.30E-20 | 151.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | TGRH88_017420 |
TGRH88_017420 |
Toxoplasma gondii | 3dxn_a | Q3HNM6 | 99.30 | 7.50E-17 | 9.40E-21 | 151.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | PDPK1 PDK1 |
3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Endometrial Cancer,Noonan Syndrome 1,Esophageal Adenosquamous Carcinoma,Prostate Cancer,Tuberous Sclerosis 1,Lung Cancer |
1h1w_a | O15530 | ENSG00000140992 | PDPK1 | 99.40 | 4.20E-17 | 5.30E-21 | 152.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDKL2 |
Cyclin-dependent kinase-like 2 (EC 2.7.11.22) (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE) |
2.7.11.22 | Homo sapiens | Papillary Serous Adenocarcinoma,Orofaciodigital Syndrome Vi |
4aaa_a | Q92772 | ENSG00000138769 | CDKL2 | 99.40 | 2.30E-17 | 2.80E-21 | 160.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PAK4 KIAA1142 |
Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) |
2.7.11.1 | Homo sapiens | Polycystic Kidney Disease 3 With Or Without Polycystic Liver Disease |
2j0i_a | O96013 | ENSG00000130669 | PAK4 | 99.30 | 6.40E-17 | 7.90E-21 | 153.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PAK6 PAK5 |
Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) |
2.7.11.1 | Homo sapiens | 4ks7_a | Q9NQU5 | ENSG00000137843 | BUB1B-PAK6 | 99.30 | 5.70E-17 | 7.30E-21 | 151.20 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | RAD53 MEC2 SAD1 SPK1 YPL153C P2588 |
Serine/threonine-protein kinase RAD53 (EC 2.7.12.1) (CHEK2 homolog) (Serine-protein kinase 1) |
2.7.12.1 | Saccharomyces cerevisiae | 4pdp_a | P22216 | 99.40 | 1.20E-17 | 1.50E-21 | 161.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | CLK1 CLK |
Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1) |
2.7.12.1 | Homo sapiens | Pick Disease Of Brain |
6ft8_a | P49759 | ENSG00000013441 | CLK1 | 99.30 | 8.00E-17 | 1.00E-20 | 152.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDK5 CDKN5 |
Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) |
2.7.11.1 | Homo sapiens | Cerebellar Hypoplasia,Supranuclear Palsy, Progressive, 1,Polycystic Kidney Disease,Dyslexia,Alzheimer Disease,Amyotrophic Lateral Sclerosis 1,Transient Cerebral Ischemia,Giant Axonal Neuropathy 2,Motor Neuron Disease,Neuroblastoma,Hereditary Spastic Paraplegia,Nephronophthisis,Alzheimer Disease 9,Scrapie,Parkinson Disease, Late-Onset,Lissencephaly With Cerebellar Hypoplasia,Pick Disease Of Brain,Ischemia,Developmental And Epileptic Encephalopathy 5,Disease Of Mental Health,Toxic Encephalopathy,Dementia, Lewy Body,Lissencephaly,Aneurysmal Bone Cysts,Lissencephaly 7 With Cerebellar Hypoplasia,Syndromic Intellectual Disability,Non-Syndromic Intellectual Disability,Multiple System Atrophy 1,Myasthenic Syndrome, Congenital, 19,Primary Autosomal Recessive Microcephaly,C Syndrome,Lung Cancer |
4au8_b | Q00535 | ENSG00000164885 | CDK5 | 99.50 | 3.30E-18 | 4.30E-22 | 158.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PKN1 PAK1 PKN PRK1 PRKCL1 |
Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N) |
2.7.11.13 | Homo sapiens | 4otd_a | Q16512 | ENSG00000123143 | PKN1 | 99.40 | 2.10E-17 | 2.60E-21 | 159.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | PTSG_10090 |
PTSG_10090 |
2.7.11.17 | Salpingoeca rosetta | 5ig1_b | F2UPG5 | 99.40 | 9.20E-18 | 1.10E-21 | 164.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | STRADA LYK5 STRAD |
STE20-related kinase adapter protein alpha (STRAD alpha) (STE20-related adapter protein) (Serologically defined breast cancer antigen NY-BR-96) |
Homo sapiens | Epilepsy,Polyhydramnios,Endometrial Squamous Cell Carcinoma,Breast Cancer,Megalencephaly,Benign Epilepsy With Centrotemporal Spikes,Scheuermann Disease,Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy |
2wtk_b | Q7RTN6 | ENSG00000266173 | STRADA | 99.40 | 1.20E-17 | 1.50E-21 | 164.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | ssp2 SPCC74.03c |
SNF1-like protein kinase ssp2 (EC 2.7.11.1) |
2.7.11.1 | Schizosaccharomyces pombe | 3h4j_b | O74536 | 99.30 | 1.00E-16 | 1.20E-20 | 155.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | MAP3K14 NIK |
Mitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25) (NF-kappa-beta-inducing kinase) (HsNIK) (Serine/threonine-protein kinase NIK) |
2.7.11.25 | Homo sapiens | T-Cell Lymphoblastic Leukemia/Lymphoma,Nik Deficiency,Trichohepatoenteric Syndrome 1,Pancreatic Adenosquamous Carcinoma,Pancreatic Ductal Adenocarcinoma,Immunodeficiency 50 |
4idv_c | Q99558 | ENSG00000006062 | MAP3K14 | 99.40 | 1.10E-17 | 1.40E-21 | 162.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | SNF1 CAT1 CCR1 GLC2 PAS14 YDR477W D8035.20 |
Carbon catabolite-derepressing protein kinase (EC 2.7.11.1) (Sucrose nonfermentating protein 1) |
2.7.11.1 | Saccharomyces cerevisiae | 2fh9_a | P06782 | 99.40 | 1.70E-17 | 2.20E-21 | 153.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | Map3k14 Nik |
Mitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25) (NF-kappa-beta-inducing kinase) (Serine/threonine-protein kinase NIK) |
2.7.11.25 | Mus musculus | 4g3f_a | Q9WUL6 | 99.50 | 1.60E-18 | 2.00E-22 | 166.60 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | MAPK1 ERK2 PRKM1 PRKM2 |
Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) |
2.7.11.24 | Homo sapiens | Pancreatic Adenocarcinoma,Heart Disease,Learning Disability,Endometrial Cancer,Autosomal Dominant Polycystic Kidney Disease,Differentiating Neuroblastoma,Squamous Cell Carcinoma,Vascular Disease,Lung Cancer Susceptibility 3,Spinal Cord Injury,Polycystic Kidney Disease,Melanoma,Leukemia, Chronic Myeloid,Thyroid Gland Anaplastic Carcinoma,Diabetes Mellitus,Noonan Syndrome 13,Alzheimer Disease,Rasopathy,Retrograde Amnesia,Bile Duct Cancer,Specific Learning Disability,Human Cytomegalovirus Infection,Hepatitis,Mesangial Proliferative Glomerulonephritis,Insulin-Like Growth Factor I,Neuroblastoma,Angioimmunoblastic T-Cell Lymphoma,Glioma,Noonan Syndrome 1,Dilated Cardiomyopathy,Bladder Cancer,Lung Adenoma,Pediculus Humanus Corporis Infestation,Cystic Kidney Disease,Ovarian Cancer,Myeloid Leukemia,Burkitt Lymphoma,Tuberous Sclerosis,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Microphthalmia,Colorectal Cancer,Hepatocellular Carcinoma,Cardiofaciocutaneous Syndrome 1,Microcephaly,Opioid Addiction,Pheochromocytoma,Rhabdomyosarcoma,Hepatitis C Virus,Alacrima, Achalasia, And Mental Retardation Syndrome,Mood Disorder,Esophagus Sarcoma,Sarcoma,Anhidrosis,Pertussis,Fibrosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Cholangiocarcinoma,Cervical Cancer,Bladder Squamous Cell Carcinoma,Fragile X Syndrome,Bladder Urothelial Carcinoma,Esophageal Cancer,Muscle Hypertrophy,Fibrodysplasia Ossificans Progressiva,Chromosome 22q11.2 Deletion Syndrome, Distal,Ewing Sarcoma,Heart, Malformation Of,Acute Promyelocytic Leukemia,Kaposi Sarcoma,Cardiomyopathy, Familial Hypertrophic, 25,Lung Cancer,Gordon Holmes Syndrome,Pancreatic Cancer |
4zzn_a | P28482 | ENSG00000100030 | MAPK1 | 99.40 | 1.80E-17 | 2.30E-21 | 160.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PLK1 PLK |
Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) |
2.7.11.21 | Homo sapiens | Breast Papillomatosis,Squamous Cell Carcinoma,Cornelia De Lange Syndrome,Leukemia, Chronic Myeloid,Gonococcal Keratitis,Leukemia, Acute Myeloid,Trichothiodystrophy 1, Photosensitive,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Microcephaly,Rhabdomyosarcoma,Gastric Cancer,Prostate Cancer,Lung Squamous Cell Carcinoma,Lymphoma, Non-Hodgkin, Familial,Dyskeratosis Congenita, Autosomal Dominant 3,Esophageal Cancer,Brain Glioma,Ataxia-Telangiectasia,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer,Pancreatic Cancer |
2rku_a | P53350 | ENSG00000166851 | PLK1 | 99.30 | 5.10E-17 | 6.40E-21 | 152.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CRK2 PK5 |
Cell division control protein 2 homolog (EC 2.7.11.22) (EC 2.7.11.23) (PfPK5) |
2.7.11.22,2.7.11.23, | Plasmodium falciparum | 1v0b_a | Q07785 | 99.30 | 6.40E-17 | 8.30E-21 | 150.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | MPK6 At2g43790 F18O19.10 |
Mitogen-activated protein kinase 6 (AtMPK6) (MAP kinase 6) (EC 2.7.11.24) |
2.7.11.24 | Arabidopsis thaliana | 6dtl_a | Q39026 | 99.40 | 4.40E-17 | 5.40E-21 | 160.20 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 |
Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) |
2.7.11.1 | Homo sapiens | Endometrial Cancer,Melanoma,Plasma Cell Neoplasm,Uterine Corpus Cancer,Atypical Teratoid Rhabdoid Tumor,Neuroblastoma,Childhood Malignant Schwannoma,Adult Malignant Schwannoma,Bladder Cancer,Laryngeal Squamous Cell Carcinoma,Tetraploidy,Ovarian Cancer,Prostate Neuroendocrine Neoplasm,Breast Cancer,Colorectal Cancer,Endometrial Serous Adenocarcinoma,Hepatocellular Carcinoma,Rhabdomyosarcoma,Gastric Cancer,Prostate Cancer,Cervical Cancer,Lynch Syndrome,Esophageal Cancer,Donohue Syndrome,Colorectal Adenocarcinoma,Myeloma, Multiple,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer,Pancreatic Cancer |
3h10_a | O14965 | ENSG00000087586 | AURKA | 99.40 | 1.50E-17 | 1.90E-21 | 152.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | TTN |
Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14) |
2.7.11.1 | Homo sapiens | Muscular Disease,Heart Disease,Constrictive Pericarditis,Congenital Fiber-Type Disproportion,Mitral Valve Insufficiency,Aortic Valve Disease 2,Congenital Structural Myopathy,Myopathy,Amyloidosis,Cardiomyopathy, Dilated, 1e,Syncope,Myofibrillar Myopathy,Atrial Heart Septal Defect,Mitochondrial Dna Depletion Syndrome 12b,Childhood-Onset Progressive Contractures-Limb-Girdle Weakness-Muscle Dystrophy Syndrome,Emery-Dreifuss Muscular Dystrophy,Cortical Thymoma,Muscle Tissue Disease,Morvan'S Fibrillary Chorea,Neuromuscular Disease,Hypertrophic Cardiomyopathy,Familial Isolated Dilated Cardiomyopathy,Rasopathy,Autosomal Dominant Distal Myopathy,Lung Large Cell Carcinoma,Myopathy, Distal, 1,Myositis,Myotonic Dystrophy 1,Systolic Heart Failure,Myopathy, Myofibrillar, 1,Diastolic Heart Failure,Autosomal Recessive Limb-Girdle Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2a,Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2g,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2j,Muscular Atrophy,Tibial Muscular Dystrophy,Limb-Girdle Muscular Dystrophy,Arrhythmogenic Right Ventricular Dysplasia, Familial, 1,Epithelial Malignant Thymoma,Hyaline Body Myopathy,Isolated Elevated Serum Creatine Phosphokinase Levels,Noonan Syndrome 1,Newborn Respiratory Distress Syndrome,Thymus Clear Cell Carcinoma,Reducing Body Myopathy,Myocarditis,Atrial Standstill 1,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 10,Hereditary Proximal Myopathy With Early Respiratory Failure,Dilated Cardiomyopathy,Alcoholic Cardiomyopathy,Lmna-Related Dilated Cardiomyopathy,Thymus Gland Disease,Long Qt Syndrome,Cardiomyopathy, Dilated, 1dd,Heart Conduction Disease,Udd Distal Myopathy - Tibial Muscular Dystrophy,Muscular Dystrophy, Congenital, Lmna-Related,Neuropathy,Perinephritis,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Right Dominant Form,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Biventricular Form,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Left Dominant Form,Myopathy, Myofibrillar, 3,Sick Sinus Syndrome,Multiminicore Disease,Cardiomyopathy, Familial Hypertrophic, 4,Cardiomyopathy, Dilated, 1a,Congestive Heart Failure,Myopathy, Myofibrillar, 4,Left Ventricular Noncompaction 2,Foot Drop,Myopathy, Myofibrillar, 5,Rhabdomyosarcoma,Rigid Spine Muscular Dystrophy 1,Epidermolysis Bullosa Simplex With Muscular Dystrophy,Thymoma,Thymus Cancer,Dendritic Cell Thymoma,Respiratory Failure,Centronuclear Myopathy,Myopathy, Myofibrillar, 9, With Early Respiratory Failure,Cardiomyopathy, Dilated, 1g,Congenital Myasthenic Syndrome,Cardiomyopathy, Familial Hypertrophic, 9,Cardiomyopathy, Dilated, 1h,Orthostatic Intolerance,Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant,Lung Squamous Cell Carcinoma,Restrictive Cardiomyopathy,Extrinsic Cardiomyopathy,Lambert-Eaton Myasthenic Syndrome,Arrhythmogenic Right Ventricular Cardiomyopathy,Brugada Syndrome,Muscle Hypertrophy,Salih Myopathy,Nonaka Myopathy,Primary Cutaneous Amyloidosis,Distal Arthrogryposis,Familial Atrial Fibrillation,Hypermethioninemia Due To Adenosine Kinase Deficiency,Atrioventricular Block,Third-Degree Atrioventricular Block,Barth Syndrome,Cardioneuromyopathy With Hyaline Masses And Nemaline Rods,Cardiomyopathy, Familial Hypertrophic, 1,Wolff-Parkinson-White Syndrome,Muscular Dystrophy-Dystroglycanopathy , Type C, 5,Intrinsic Cardiomyopathy,Peripartum Cardiomyopathy,Lipoprotein Quantitative Trait Locus,Atrial Fibrillation,Scoliosis,Muscular Dystrophy, Duchenne Type,Myopathy, Centronuclear, X-Linked,Cardiac Arrest,Inguinal Hernia,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 2,Myasthenia Gravis,Left Ventricular Noncompaction,Lethal Congenital Contracture Syndrome,Myopathy, Centronuclear, 2,Batten-Turner Congenital Myopathy,Miyoshi Muscular Dystrophy,Tibial Muscular Dystrophy, Tardive,Cardiomyopathy, Dilated, 1b |
1tki_b | Q8WZ42 | ENSG00000155657 | TTN | 99.40 | 7.60E-18 | 9.40E-22 | 161.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | OXSR1 KIAA1101 OSR1 |
Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) |
2.7.11.1 | Homo sapiens | Bartter Disease,Arthrogryposis, Distal, Type 3,Hypomagnesemia 4, Renal,Distal Arthrogryposis,Hypomagnesemia 3, Renal |
2vwi_c | O95747 | ENSG00000172939 | OXSR1 | 99.40 | 9.60E-18 | 1.30E-21 | 155.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | Wnk1 Hsn2 Prkwnk1 |
Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) |
2.7.11.1 | Rattus norvegicus | 5drb_a | Q9JIH7 | 99.30 | 7.80E-17 | 1.00E-20 | 149.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | Rps6ka3 Mapkapk1b Rps6ka-rs1 Rsk2 |
Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) |
2.7.11.1 | Mus musculus | 4el9_a | P18654 | 99.30 | 8.40E-17 | 1.10E-20 | 152.30 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C |
Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) |
2.7.11.24 | Homo sapiens | Liver Disease,Endometrial Cancer,Lung Cancer Susceptibility 3,Non-Alcoholic Fatty Liver Disease,Hepatitis C,Acantholytic Acanthoma,Leukemia, Chronic Myeloid,Diabetes Mellitus,Non-Alcoholic Steatohepatitis,Fatty Liver Disease,Alzheimer Disease,Epidermolysis Bullosa Simplex,Hepatitis,Colon Adenocarcinoma,Neuroblastoma,Cervical Non-Keratinizing Squamous Cell Carcinoma,Hereditary Spastic Paraplegia,Leukemia, Acute Lymphoblastic,Ovarian Cancer,Burkitt Lymphoma,Breast Cancer,Glioblastoma,Parkinson Disease, Late-Onset,Colorectal Cancer,Hepatocellular Carcinoma,Sarcoma,Fibrosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Rheumatoid Arthritis,Type 2 Diabetes Mellitus,Renal Fibrosis,Acute Promyelocytic Leukemia,Huntington Disease,Nasopharyngeal Carcinoma,Cardiomyopathy, Familial Hypertrophic, 25,Neu-Laxova Syndrome 1,Lung Cancer,Pancreatic Cancer |
2xrw_a | P45983 | ENSG00000107643 | MAPK8 | 99.30 | 8.00E-17 | 9.80E-21 | 158.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | pknE Rv1743 MTCY28.05 |
Serine/threonine-protein kinase PknE (EC 2.7.11.1) |
2.7.11.1 | Mycobacterium tuberculosis | 2h34_a | P9WI77 | 99.30 | 5.00E-17 | 6.30E-21 | 154.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | ROCK1 |
Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) |
2.7.11.1 | Homo sapiens | Coronary Artery Vasospasm,Ocular Hyperemia,Breast Cancer,Pediatric Osteosarcoma,Hutchinson-Gilford Progeria Syndrome,Tetralogy Of Fallot,Hypertension, Essential,Lung Cancer |
2v55_c | Q13464 | ENSG00000067900 | ROCK1 | 99.40 | 3.70E-17 | 4.40E-21 | 164.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | STK38 NDR1 |
Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1) |
2.7.11.1 | Homo sapiens | Myeloproliferative Syndrome, Transient,Wilson-Turner X-Linked Mental Retardation Syndrome |
6bxi_a | Q15208 | ENSG00000112079 | STK38 | 99.30 | 9.20E-17 | 1.10E-20 | 154.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | BN1205_040370 TGVEG_207820 |
BN1205_040370 TGVEG_207820 |
2.7.11.24 | Toxoplasma gondii | 3rp9_a | B6KP12 | 99.50 | 1.50E-18 | 1.90E-22 | 175.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | ULK3 |
Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) |
2.7.11.1 | Homo sapiens | 6fdy_u | Q6PHR2 | ENSG00000140474 | ULK3 | 99.40 | 1.90E-17 | 2.50E-21 | 152.30 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | PBL2 APK2A KIN1 At1g14370 F14L17.14 |
Probable serine/threonine-protein kinase PBL2 (EC 2.7.11.1) (PBS1-like protein 2) (Protein kinase 2A) |
2.7.11.1 | Arabidopsis thaliana | 6j5t_d | O49839 | 99.40 | 5.10E-18 | 6.20E-22 | 170.50 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | CAMKK2 CAMKKB KIAA0787 |
Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta) |
2.7.11.17 | Homo sapiens | Parkinson Disease, Late-Onset |
5uy6_a | Q96RR4 | ENSG00000110931 | CAMKK2 | 99.30 | 6.50E-17 | 8.40E-21 | 149.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | INSR |
Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] |
2.7.10.1 | Homo sapiens | Acanthosis Nigricans,Liver Disease,Heart Disease,Autosomal Dominant Polycystic Kidney Disease,Hyperglycemia,Hypertrichosis,Islet Cell Tumor,Myopathy,Polycystic Ovary Syndrome,Hyperandrogenism,Non-Alcoholic Fatty Liver Disease,Gestational Diabetes,Prediabetes Syndrome,Diabetes Mellitus,Fatty Liver Disease,Hyperinsulinism,Alzheimer Disease,Myotonic Disease,Myotonic Dystrophy 1,Fasting Hypoglycemia,Insulin-Like Growth Factor I,Fetal Macrosomia,Hypoglycemia,Liver Cirrhosis,Migraine With Aura,Insr-Related Severe Syndromic Insulin Resistance,Pigmentation Disease,Type 1 Diabetes Mellitus,Hyperinsulinemic Hypoglycemia,Ovarian Cancer,Adenocarcinoma,Glucose Intolerance,Breast Cancer,Colorectal Cancer,Lipid Metabolism Disorder,Ovarian Disease,Hyperinsulinemic Hypoglycemia, Familial, 5,Hyperinsulinemic Hypoglycemia, Familial, 4,Centronuclear Myopathy,Body Mass Index Quantitative Trait Locus 11,Diabetes Mellitus, Insulin-Resistant, With Acanthosis Nigricans,Type 2 Diabetes Mellitus,Abdominal Obesity-Metabolic Syndrome 1,Congenital Generalized Lipodystrophy,Maturity-Onset Diabetes Of The Young,Donohue Syndrome,Hypertension, Essential,Pineal Hyperplasia, Insulin-Resistant Diabetes Mellitus, And Somatic Abnormalities |
3bu3_a | P06213 | ENSG00000171105 | INSR | 99.30 | 6.40E-17 | 8.40E-21 | 150.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | Tyk2 |
Non-receptor tyrosine-protein kinase TYK2 (EC 2.7.10.2) |
2.7.10.2 | Mus musculus | 4e1z_a | Q9R117 | 99.30 | 7.10E-17 | 9.40E-21 | 148.10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Cricetulus griseus | 5n3j_a | P25321 | 99.30 | 1.10E-16 | 1.30E-20 | 155.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | RPS6KA3 ISPK1 MAPKAPK1B RSK2 |
Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) |
2.7.11.1 | Homo sapiens | Ventricular Septal Defect,Learning Disability,Symptomatic Form Of Coffin-Lowry Syndrome In Female Carriers,Cohen Syndrome,Specific Learning Disability,Gastroesophageal Reflux,Breast Cancer,Cardiomyopathy, Familial Hypertrophic, 4,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Chromosome 16p13.3 Deletion Syndrome, Proximal,Orthostatic Intolerance,Dyskeratosis Congenita, Autosomal Dominant 3,X-Linked Monogenic Disease,Non-Syndromic X-Linked Intellectual Disability,Coffin-Lowry Syndrome,Hypertelorism,Partington X-Linked Mental Retardation Syndrome,Scoliosis |
4d9u_a | P51812 | ENSG00000177189 | RPS6KA3 | 99.40 | 3.70E-17 | 4.50E-21 | 158.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PRKCQ PRKCT |
Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) |
2.7.11.13 | Homo sapiens | Inflammatory Bowel Disease 1,T-Cell Lymphoblastic Leukemia/Lymphoma,Crohn'S Disease,Breast Cancer,Gastrointestinal Stromal Tumor |
4ra5_a | Q04759 | ENSG00000065675 | PRKCQ | 99.30 | 1.10E-16 | 1.30E-20 | 154.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ROCK2 |
Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) |
2.7.11.1 | Bos taurus | 2f2u_b | Q28021 | 99.50 | 2.80E-18 | 3.40E-22 | 172.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | CHEK1 CHK1 |
Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) |
2.7.11.1 | Homo sapiens | Tongue Carcinoma,Neuroblastoma,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Cerebellar Disease,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Microcephaly,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Retinoblastoma,Esophageal Cancer,Seckel Syndrome,Mantle Cell Lymphoma,Pigmentary Disorder, Reticulate, With Systemic Manifestations, X-Linked,Ovarian Clear Cell Carcinoma,Autosomal Recessive Cerebellar Ataxia,Li-Fraumeni Syndrome,Ataxia-Telangiectasia,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer |
2e9v_b | O14757 | ENSG00000149554 | CHEK1 | 99.50 | 9.40E-19 | 1.20E-22 | 159.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ULK2 KIAA0623 |
Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) |
2.7.11.1 | Homo sapiens | 6qau_a | Q8IYT8 | ENSG00000083290 | ULK2 | 99.30 | 9.10E-17 | 1.20E-20 | 147.50 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | STK17B DRAK2 |
Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2) |
2.7.11.1 | Homo sapiens | Colon Squamous Cell Carcinoma |
3lm5_a | O94768 | ENSG00000081320 | STK17B | 99.50 | 3.60E-18 | 4.40E-22 | 165.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PLK3 CNK FNK PRK |
Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) |
2.7.11.21 | Homo sapiens | Breast Cancer |
4b6l_a | Q9H4B4 | ENSG00000173846 | PLK3 | 99.40 | 1.80E-17 | 2.30E-21 | 153.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PHO85 SSG3 YPL031C P7102.18A |
Cyclin-dependent protein kinase PHO85 (EC 2.7.11.22) (Negative regulator of the PHO system) (Serine/threonine-protein kinase PHO85) |
2.7.11.22 | Saccharomyces cerevisiae | 4krd_a | P17157 | 99.30 | 5.90E-17 | 7.30E-21 | 154.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | KDR FLK1 VEGFR2 |
Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309) |
2.7.10.1 | Homo sapiens | Psoriasis,Pancreatic Adenocarcinoma,Corneal Neovascularization,Mesothelioma, Malignant,Skin Melanoma,Pneumothorax,Heart Disease,Neovascular Glaucoma,Endocrine Gland Cancer,Retinal Vein Occlusion,Retinal Vascular Occlusion,Vascular Cancer,Retinitis Pigmentosa,Thyroid Gland Cancer,Ovarian Hyperstimulation Syndrome,Lung Cancer Susceptibility 3,Chronic Myelomonocytic Leukemia,Bone Cancer,Microvascular Complications Of Diabetes 5,Mast-Cell Leukemia,Melanoma,Malignant Ciliary Body Melanoma,Lung Non-Squamous Non-Small Cell Carcinoma,Diabetes Mellitus,Degeneration Of Macula And Posterior Pole,Macular Retinal Edema,Clear Cell Renal Cell Carcinoma,Septate Uterus,Primary Cutaneous B-Cell Lymphoma,Myocardial Infarction,Breast Angiosarcoma,Eye Degenerative Disease,Placenta Accreta,Cavernous Hemangioma,Neuroblastoma,Pilocytic Astrocytoma,Epithelioid Hemangioendothelioma,Arteriovenous Malformations Of The Brain,Olecranon Bursitis,Pulmonary Vein Stenosis,Retinal Vascular Disease,Gastroesophageal Junction Adenocarcinoma,Leukemia, Acute Myeloid,Capillary Disease,Hematologic Cancer,Hemangioma,Radiation Proctitis,Kidney Cancer,Leukostasis,Aortic Valve Disease 1,Hemangioblastoma,Bladder Cancer,Capillary Hemangioma,Heritable Pulmonary Arterial Hypertension,Retinal Artery Occlusion,Fundus Dystrophy,Parasitic Protozoa Infectious Disease,Kaposiform Hemangioendothelioma,Nodular Goiter,Background Diabetic Retinopathy,Endometriosis,Pediculus Humanus Capitis Infestation,Vein Disease,Bursitis,Ovarian Cancer,Hemangioma, Capillary Infantile,Adenocarcinoma,Pre-Eclampsia,Eye Disease,Cervical Adenosquamous Carcinoma,Breast Carcinoma In Situ,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Rosacea,High Grade Glioma,Gliosarcoma,Colorectal Cancer,Familial Hypercholesterolemia,Hepatocellular Carcinoma,Proctitis,Premature Menopause,8p11 Myeloproliferative Syndrome,Clopidogrel Resistance,Kuhnt-Junius Degeneration,Angiokeratoma Of Mibelli,Angiokeratoma Circumscriptum,Pheochromocytoma,Rhabdomyosarcoma,Ischemia,Cerebral Cavernous Malformations,Conjunctival Vascular Disease,Macular Degeneration, Age-Related, 1,Sarcoma,Hantavirus Pulmonary Syndrome,Fibrosarcoma Of Bone,Skin Carcinoma,Gastric Cancer,Lymphangioma,Mobitz Type Ii Atrioventricular Block,Prostate Cancer,Disease Of Mental Health,Coats Disease,Microvascular Complications Of Diabetes 1,Pulmonary Hypertension,Type 2 Diabetes Mellitus,Angiosarcoma,Drug-Induced Lupus Erythematosus,Placental Insufficiency,Thyroid Gland Follicular Carcinoma,Merkel Cell Carcinoma,Thyroid Gland Medullary Carcinoma,Renal Cell Carcinoma, Papillary, 1,Esophageal Cancer,Exudative Vitreoretinopathy 1,Tetralogy Of Fallot,Myelodysplastic Syndrome,Sorsby Fundus Dystrophy,Ewing Sarcoma,Gastrointestinal Stromal Tumor,Varicose Veins,Hirschsprung Disease 1,Limb Ischemia,Bone Squamous Cell Carcinoma,Renal Cell Carcinoma, Nonpapillary,Mucosal Melanoma,Hypertension, Essential,Lipoprotein Quantitative Trait Locus,Cardiovascular Organ Benign Neoplasm,Intussusception,Moyamoya Disease 1,Premature Ovarian Failure 1,Medulloblastoma,Lung Cancer,Pancreatic Cancer |
4ase_a | P35968 | ENSG00000128052 | KDR | 99.40 | 2.40E-17 | 3.00E-21 | 159.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | Mapk1 Erk2 Mapk Prkm1 |
Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) |
2.7.11.24 | Rattus norvegicus | 4xne_a | P63086 | 99.30 | 8.80E-17 | 1.10E-20 | 156.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | MAPK7 BMK1 ERK5 PRKM7 |
Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5) |
2.7.11.24 | Homo sapiens | Bone Cancer,Noma,Primary Bone Cancer,Dilated Cardiomyopathy,Breast Cancer,Prostate Cancer,Osteogenesis Imperfecta, Type Xviii,Scoliosis, Isolated 1,Scoliosis |
4zsg_a | Q13164 | ENSG00000166484 | MAPK7 | 99.50 | 2.10E-18 | 2.70E-22 | 166.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDK13 CDC2L CDC2L5 CHED KIAA1791 |
Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller) |
2.7.11.22,2.7.11.23, | Homo sapiens | Corneal Endothelial Dystrophy,Neuroblastoma,Congenital Heart Defects, Dysmorphic Facial Features, And Intellectual Developmental Disorder,Microcephaly,Corneal Dystrophy, Posterior Polymorphous, 1,Spinocerebellar Ataxia 14,Strabismus,White-Sutton Syndrome |
5efq_a | Q14004 | ENSG00000065883 | CDK13 | 99.30 | 7.10E-17 | 8.80E-21 | 156.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | cgd4_240 |
cgd4_240 |
Cryptosporidium parvum | 3eb0_a | A3FQN0 | 99.40 | 2.90E-17 | 3.50E-21 | 163.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | Brsk2 Kiaa4256 Sada |
Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase SAD-A) |
2.7.11.26 | Mus musculus | 4ynz_b | Q69Z98 | 99.40 | 2.40E-17 | 3.00E-21 | 159.90 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | DAPK3 ZIPK |
Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) |
2.7.11.1 | Homo sapiens | Recessive Dystrophic Epidermolysis Bullosa |
1yrp_a | O43293 | ENSG00000167657 | DAPK3 | 99.30 | 8.20E-17 | 1.10E-20 | 148.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MASTL GW GWL THC2 |
Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) |
2.7.11.1 | Homo sapiens | Autosomal Thrombocytopenia With Normal Platelets,Sick Building Syndrome,Thrombocytopenia,Thrombocytopenia 2,Gray Platelet Syndrome,Ceroid Lipofuscinosis, Neuronal, 2 |
5loh_a | Q96GX5 | ENSG00000120539 | MASTL | 99.30 | 8.40E-17 | 1.00E-20 | 156.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PHKG1 PHKG |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26) |
2.7.11.1,2.7.11.19,2.7.11.26 | Oryctolagus cuniculus | 2phk_a | P00518 | 99.40 | 1.40E-17 | 1.90E-21 | 151.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | PLK2 SNK |
Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) |
2.7.11.21 | Homo sapiens | Epilepsy, Familial Temporal Lobe, 2 |
4i5p_a | Q9NYY3 | ENSG00000145632 | PLK2 | 99.40 | 3.70E-17 | 4.60E-21 | 156.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PRKCH PKCL PRKCL |
Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) |
2.7.11.13 | Homo sapiens | Myofibrillar Myopathy,Amphetamine Abuse,Stroke, Ischemic,Glioblastoma |
3txo_a | P24723 | ENSG00000027075 | PRKCH | 99.40 | 2.30E-17 | 2.80E-21 | 160.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDK7 CAK CAK1 CDKN7 MO15 STK1 |
Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) |
2.7.11.22,2.7.11.23, | Homo sapiens | Myofibrillar Myopathy,Cockayne Syndrome,Breast Cancer,Xeroderma Pigmentosum, Complementation Group D,Xeroderma Pigmentosum, Variant Type,Xeroderma Pigmentosum, Complementation Group B |
1ua2_b | P50613 | ENSG00000134058 | CDK7 | 99.40 | 1.10E-17 | 1.40E-21 | 161.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MAP2K1 MEK1 PRKMK1 |
Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) |
2.7.12.2 | Homo sapiens | Melorheostosis, Isolated,Skin Melanoma,Achondroplasia,Heart Disease,Ichthyosis,Squamous Cell Carcinoma,Cerebral Hemisphere Lipoma,Corpus Callosum Lipoma,Lung Cancer Susceptibility 3,Melorheostosis,Pulmonary Valve Stenosis,Suppression Of Tumorigenicity 12,Melanoma,Acneiform Dermatitis,Neurofibromatosis-Noonan Syndrome,Hypertrophic Cardiomyopathy,Osteopoikilosis,Alzheimer Disease,Rasopathy,Noonan Syndrome-Like Disorder With Loose Anagen Hair,Keratosis Pilaris Atrophicans Faciei,Costello Syndrome,Anthrax Disease,Extracranial Arteriovenous Malformation,Neurofibromatosis, Type I,Neuroblastoma,Skin Granular Cell Tumor,Pseudo-Turner Syndrome,Leukemia, Acute Myeloid,Noonan Syndrome 1,Senile Angioma,Hemangioma,Rosai-Dorfman Disease,Bladder Cancer,Mixed Cell Adenoma,Hairy Cell Leukemia,Prostate Squamous Cell Carcinoma,Noonan Syndrome-Like Disorder With Loose Anagen Hair 2,Cardiofaciocutaneous Syndrome 3,Ovarian Cancer,Myeloid Leukemia,Adenocarcinoma,Breast Cancer,Squamous Cell Carcinoma, Head And Neck,Colorectal Cancer,Pulmonary Valve Disease,Hepatocellular Carcinoma,Cardiofaciocutaneous Syndrome 1,Splenic Diffuse Red Pulp Small B-Cell Lymphoma,Pheochromocytoma,Rhabdomyosarcoma,Noonan Syndrome With Multiple Lentigines,Fibrosarcoma,Histiocytosis,Skin Carcinoma,Gastric Cancer,Arteriovenous Malformation,Prostate Cancer,Disease Of Mental Health,Gastric Adenocarcinoma,Langerhans Cell Histiocytosis,Bladder Urothelial Carcinoma,Lymphoma, Non-Hodgkin, Familial,Diamond-Blackfan Anemia 20,Acute Promyelocytic Leukemia,Ovarian Melanoma,Autism Spectrum Disorder,Kaposi Sarcoma,Cardiomyopathy, Familial Hypertrophic, 25,Medulloblastoma,Autism,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Lung Cancer,Pancreatic Cancer |
3sls_b | Q02750 | ENSG00000169032 | MAP2K1 | 99.30 | 1.10E-16 | 1.40E-20 | 151.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | unc-22 ZK617.1 |
Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) |
2.7.11.1 | Caenorhabditis elegans | 3uto_a | Q23551 | 99.40 | 1.30E-17 | 1.60E-21 | 172.50 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | PLK4 SAK STK18 |
Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak) |
2.7.11.21 | Homo sapiens | Congenital Nervous System Abnormality,Autosomal Recessive Chorioretinopathy-Microcephaly Syndrome,Colorectal Cancer,Microcephaly,Seckel Syndrome,Microcephaly And Chorioretinopathy, Autosomal Recessive, 2,Isolated Growth Hormone Deficiency,Primary Autosomal Recessive Microcephaly,Joubert Syndrome 1,Isolated Growth Hormone Deficiency, Type Ia |
3cok_b | O00444 | ENSG00000142731 | PLK4 | 99.40 | 7.90E-18 | 1.00E-21 | 156.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MAP4K3 RAB8IPL1 |
Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) |
2.7.11.1 | Homo sapiens | Adult-Onset Still'S Disease |
5j5t_a | Q8IVH8 | ENSG00000011566 | MAP4K3 | 99.50 | 1.60E-18 | 1.90E-22 | 170.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | RPS6KA5 MSK1 |
Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) |
2.7.11.1 | Homo sapiens | Septic Myocarditis,Coffin-Lowry Syndrome |
3kn5_b | O75582 | ENSG00000100784 | RPS6KA5 | 99.40 | 4.50E-18 | 5.60E-22 | 163.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | WNK3 KIAA1566 PRKWNK3 |
Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) |
2.7.11.1 | Homo sapiens | Bartter Disease,Renal Tubular Transport Disease,Pseudohypoaldosteronism,Agenesis Of The Corpus Callosum With Peripheral Neuropathy,Arthrogryposis, Distal, Type 3,Liddle Syndrome 1,Hypomagnesemia 4, Renal,Distal Arthrogryposis,Hypertension, Essential,Syndromic X-Linked Intellectual Disability Siderius Type,Gitelman Syndrome |
5o2c_a | Q9BYP7 | ENSG00000196632 | WNK3 | 99.40 | 3.10E-17 | 3.70E-21 | 163.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PHKG2 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) |
2.7.11.19 | Homo sapiens | Glycogen Storage Disease Ixa,Glycogen Storage Disease Ixc,Glycogen Storage Disease,Phosphorylase Kinase Deficiency,Glycogen Storage Disease Due To Liver Phosphorylase Kinase Deficiency,Glycogen Storage Disease Ia,Glycogen Storage Disease, Type Ixd,Glycogen Storage Disease Ix,Glycogen Storage Disease Ixb |
2y7j_c | P15735 | ENSG00000156873 | PHKG2 | 99.40 | 8.80E-18 | 1.10E-21 | 164.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | AKT1 PKB RAC |
RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) |
2.7.11.1 | Homo sapiens | Adult Hepatocellular Carcinoma,Breast Papillomatosis,Esophageal Disease,Pancreatic Adenocarcinoma,Muscular Disease,Skin Melanoma,Liver Disease,Mitral Valve Disease,Heart Disease,Neurofibromatosis, Type Ii,Endometrial Cancer,Bile Duct Disease,Spinal Chordoma,Hepatopulmonary Syndrome,Squamous Cell Carcinoma,Pfeiffer Syndrome,Glucose Metabolism Disease,Childhood T-Cell Acute Lymphoblastic Leukemia,Hyperglycemia,Retinitis Pigmentosa,Thyroid Gland Cancer,Hair Disease,Macroglobulinemia,Lung Cancer Susceptibility 3,Kagami-Ogata Syndrome,Adenoid Cystic Carcinoma,Non-Alcoholic Fatty Liver Disease,Chordoma,Cowden Syndrome,Polycystic Kidney Disease,Microvascular Complications Of Diabetes 5,Suppression Of Tumorigenicity 12,Melanoma,Connective Tissue Disease,Ocular Hypertension,Leukemia, Chronic Myeloid,Overnutrition,Inherited Metabolic Disorder,Thyroid Gland Anaplastic Carcinoma,Diabetes Mellitus,Adenoma,Spherocytosis, Type 5,Cowden Syndrome 1,Breast Juvenile Papillomatosis,Lipid Storage Disease,Peripheral Nervous System Neoplasm,Uterine Corpus Cancer,Connective Tissue Cancer,Bone Sarcoma,Hypertrophic Cardiomyopathy,Placental Choriocarcinoma,Leukocyte Disease,Clear Cell Renal Cell Carcinoma,Hyperostosis,Alzheimer Disease,Hepatoblastoma,Rasopathy,Nasopharyngeal Disease,Myocardial Infarction,Major Depressive Disorder,Bile Duct Cancer,Intestinal Benign Neoplasm,Stroke, Ischemic,Teeth Hard Tissue Disease,Amyotrophic Lateral Sclerosis 1,Malignant Ovarian Surface Epithelial-Stromal Neoplasm,Ovary Epithelial Cancer,T-Cell Lymphoblastic Leukemia/Lymphoma,Ocular Cancer,Amelogenesis Imperfecta,Retinal Cancer,Blood Platelet Disease,Biliary Tract Disease,Congenital Lipomatous Overgrowth, Vascular Malformations, And Epidermal Nevi,Infratentorial Cancer,Leptin Deficiency Or Dysfunction,Lymphatic System Disease,Neurofibromatosis, Type I,Insulin-Like Growth Factor I,Neuroblastoma,Colonic Benign Neoplasm,Subependymal Glioma,Blood Coagulation Disease,Benign Ependymoma,Pilocytic Astrocytoma,Diffuse Astrocytoma,Childhood Leukemia,Bile Duct Adenocarcinoma,Hemangioma Of Lung,Nevus, Epidermal,Distal Muscular Dystrophy With Anterior Tibial Onset,Retinal Vascular Disease,Psychotic Disorder,Leukemia, Acute Myeloid,Noonan Syndrome 1,Bone Marrow Cancer,Leber Plus Disease,Hemangioma,Leukemia, Acute Lymphoblastic,Cataract,Combined Immunodeficiency,Liver Cirrhosis,Pancreas Disease,Papilloma,Cardiovascular System Disease,Autonomic Nervous System Neoplasm,Kidney Cancer,Pleural Cancer,Basal Cell Nevus Syndrome,Cowden Syndrome 6,Bladder Cancer,Focal Segmental Glomerulosclerosis,Epithelial-Myoepithelial Carcinoma,Thymus Gland Disease,Brain Cancer,Colonic Disease,Lung Adenoma,Lung Oat Cell Carcinoma,Endometrial Adenocarcinoma,Oropharynx Cancer,Cervix Carcinoma,Ulcerative Colitis,Nervous System Disease,Osteoporosis,Anal Squamous Cell Carcinoma,Ovarian Cancer,Adenocarcinoma,Tuberous Sclerosis 2,In Situ Carcinoma,Tuberous Sclerosis,T-Cell Acute Lymphoblastic Leukemia,Eye Disease,Acute Megakaryocytic Leukemia,Breast Carcinoma In Situ,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Malignant Astrocytoma,Gliosarcoma,Parkinson Disease, Late-Onset,Colorectal Cancer,Peripheral Nervous System Disease,Nervous System Cancer,Ovarian Serous Cystadenocarcinoma,Cystadenocarcinoma,Serous Cystadenocarcinoma,Gallbladder Cancer,Hepatocellular Carcinoma,Premature Menopause,Combined Hepatocellular Carcinoma And Cholangiocarcinoma,Skin Papilloma,Partial Third-Nerve Palsy,Neurilemmoma,Rhabdomyosarcoma,Ischemia,Tongue Disease,Chronic Granulomatous Disease,Thymoma,Thymus Cancer,Ovarian Disease,Noonan Syndrome With Multiple Lentigines,Polycystic Kidney Disease 1 With Or Without Polycystic Liver Disease,Teratoma,Bipolar Disorder,Macular Degeneration, Age-Related, 1,Immunodeficiency 14,Sarcoma,Bone Osteosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Cone-Rod Dystrophy 2,Prostate Cancer,Disease Of Mental Health,Pancreatic Ductal Adenocarcinoma,Cholangiocarcinoma,Proteus Syndrome,Cervical Cancer,Toxic Encephalopathy,Ovarian Cystadenocarcinoma,Body Mass Index Quantitative Trait Locus 11,Penile Disease,Contractures, Pterygia, And Spondylocarpotarsal Fusion Syndrome 1a,Central Nervous System Cancer,Pulmonary Fibrosis, Idiopathic,Congenital Myasthenic Syndrome,Retinitis Pigmentosa 47,Respiratory System Disease,Integumentary System Disease,Skin Disease,Cervical Adenocarcinoma,Ovary Adenocarcinoma,Gastric Adenocarcinoma,Type 2 Diabetes Mellitus,Plasmacytoma,Cervical Squamous Cell Carcinoma,Lynch Syndrome,Hidradenoma,Lung Squamous Cell Carcinoma,Fragile X Syndrome,Thyroid Gland Follicular Carcinoma,Schizophrenia,Sensory System Disease,Bladder Urothelial Carcinoma,Lymphoma, Non-Hodgkin, Familial,Skeletal Muscle Cancer,Muscle Cancer,Small Cell Cancer Of The Lung,Immunodeficiency 36,Hypotrichosis 1,Exanthem,Esophageal Cancer,Severe Congenital Neutropenia,Respiratory System Benign Neoplasm,Reproductive Organ Benign Neoplasm,Gastrointestinal System Benign Neoplasm,Immune Deficiency Disease,Myelodysplastic Syndrome,Meningioma, Radiation-Induced,Wiskott-Aldrich Syndrome,X-Linked Monogenic Disease,Autosomal Genetic Disease,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Peripheral T-Cell Lymphoma,Tuberous Sclerosis 1,Hashimoto Thyroiditis,Gastrointestinal Stromal Tumor,Diabetic Encephalopathy,Tongue Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Huntington Disease,Renal Cell Carcinoma, Nonpapillary,Nasopharyngeal Carcinoma,Hypertension, Essential,Meningioma, Familial,Pre-Malignant Neoplasm,Lymphatic System Cancer,Ductal Carcinoma In Situ,Estrogen-Receptor Positive Breast Cancer,Cell Type Benign Neoplasm,Cardiovascular Organ Benign Neoplasm,Uterine Benign Neoplasm,Acquired Metabolic Disease,Kaposi Sarcoma,Colitis,Klippel-Trenaunay-Weber Syndrome,Gallbladder Disease,Leukemia, Chronic Lymphocytic,Amelogenesis Imperfecta, Type Ig,Systemic Lupus Erythematosus,Pelizaeus-Merzbacher Disease,Rett Syndrome,Myeloma, Multiple,Medulloblastoma,Spinal Disease,Autism,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Lymphoproliferative Syndrome,Lung Cancer,Palmoplantar Keratoderma, Bothnian Type,Oculoectodermal Syndrome,Osteogenic Sarcoma,Pancreatic Cancer |
4gv1_a | P31749 | ENSG00000142208 | AKT1 | 99.40 | 3.90E-18 | 4.80E-22 | 165.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PRKAA2 AMPK AMPK2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) |
2.7.11.27,2.7.11.31, | Homo sapiens | Hyperglycemia,Hypertrophic Cardiomyopathy,Glycogen Storage Disease,Phosphorylase Kinase Deficiency,Tuberous Sclerosis,Breast Cancer,Ischemia,Aromatase Deficiency,Peutz-Jeghers Syndrome,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Wolff-Parkinson-White Syndrome |
3aqv_a | P54646 | ENSG00000162409 | PRKAA2 | 99.30 | 5.70E-17 | 7.40E-21 | 149.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PRKAA1 AMPK1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) |
2.7.11.26,2.7.11.27,2.7.11.31 | Homo sapiens | Mixed Fibrolamellar Hepatocellular Carcinoma,Fatty Liver Disease,Breast Cancer,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Wolff-Parkinson-White Syndrome,Lung Cancer |
4red_a | Q13131 | ENSG00000132356 | PRKAA1 | 99.30 | 8.00E-17 | 9.70E-21 | 158.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PTK6 BRK |
Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) |
2.7.10.2 | Homo sapiens | Charge Syndrome,Aggressive Systemic Mastocytosis,Breast Cancer,Inclusion Conjunctivitis,Ovary Serous Adenocarcinoma,Thoracic Outlet Syndrome |
6cz4_a | Q13882 | ENSG00000101213 | PTK6 | 99.30 | 8.20E-17 | 1.10E-20 | 145.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | SAPK10 |
SAPK10 |
Saccharum officinarum | 5wax_a | A0A238LNS4 | 99.30 | 5.40E-17 | 6.70E-21 | 154.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | TNNI3K CARK |
Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase) |
2.7.11.1 | Homo sapiens | Dilated Cardiomyopathy,Restrictive Cardiomyopathy,Cardiac Conduction Disease With Or Without Dilated Cardiomyopathy,Familial Atrial Fibrillation |
4yfi_a | Q59H18 | ENSG00000259030 | FPGT-TNNI3K | 99.30 | 1.00E-16 | 1.30E-20 | 151.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ROP8 |
ROP8 |
Toxoplasma gondii | 3byv_a | O15693 | 99.40 | 2.50E-17 | 3.00E-21 | 162.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | MAP4K1 HPK1 |
Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1) |
2.7.11.1 | Homo sapiens | 6cqd_b | Q92918 | ENSG00000104814 | MAP4K1 | 99.50 | 2.80E-18 | 3.60E-22 | 160.60 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | CHEK2 CDS1 CHK2 RAD53 |
Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) |
2.7.11.1 | Homo sapiens | Squamous Cell Carcinoma,Cerebral Hemisphere Lipoma,Corpus Callosum Lipoma,Adenoid Cystic Carcinoma,Cowden Syndrome,Cervical Adenoma Malignum,Leiomyosarcoma,Bilateral Breast Cancer,B-Lymphoblastic Leukemia/Lymphoma,Diffuse Midline Glioma, H3 K27m-Mutant,Essential Thrombocythemia,Congenital Heart Defects, Multiple Types, 3,Familial Colorectal Cancer,Leukemia,Inherited Cancer-Predisposing Syndrome,Wilms Tumor 5,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Li-Fraumeni Syndrome 1,Telangiectasis,Basal Cell Carcinoma,Lung Leiomyosarcoma,Prostate Leiomyosarcoma,Cerebellar Disease,Bile Duct Cystadenoma,T-Cell Prolymphocytic Leukemia,Nk-Cell Enteropathy,Ovarian Cancer,Breast Cancer,Hereditary Breast Ovarian Cancer Syndrome,Colorectal Cancer,Li-Fraumeni Syndrome 2,Premature Menopause,Rhabdomyosarcoma,Xeroderma Pigmentosum, Variant Type,Sarcoma,Fanconi Anemia, Complementation Group A,Bone Osteosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Thrombocytopenia,Lynch Syndrome,Esophageal Cancer,Seckel Syndrome,Myelodysplastic Syndrome,Gastric Cancer, Hereditary Diffuse,Tumor Predisposition Syndrome,Cutaneous Telangiectasia And Cancer Syndrome, Familial,Wilms Tumor 1,Autosomal Recessive Cerebellar Ataxia,Lymphoma,Nijmegen Breakage Syndrome,Colitis,Li-Fraumeni Syndrome,Premature Ovarian Failure 1,Ataxia-Telangiectasia,Melanoma, Cutaneous Malignant 1,Lung Cancer,Osteogenic Sarcoma |
3i6u_a | O96017 | ENSG00000183765 | CHEK2 | 99.30 | 6.80E-17 | 8.00E-21 | 163.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | SNRK KIAA0096 SNFRK |
SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase) |
2.7.11.1 | Homo sapiens | Breast Angiosarcoma,Skin Angiosarcoma,Liver Angiosarcoma,Skin Sarcoma,Lymphangiosarcoma,Breast Sarcoma,Hydrolethalus Syndrome 1,Neuronopathy, Distal Hereditary Motor, Type Viii |
5yks_b | Q9NRH2 | ENSG00000163788 | SNRK | 99.40 | 1.40E-17 | 1.70E-21 | 166.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | RPS6KB1 STK14A |
Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) |
2.7.11.1 | Homo sapiens | Mitral Valve Disease,Retinitis Pigmentosa,Cowden Syndrome,Pyriform Sinus Cancer,Cowden Syndrome 1,Placental Choriocarcinoma,Uterus Perivascular Epithelioid Cell Tumor,Subependymal Glioma,Benign Ependymoma,Leukemia, Acute Myeloid,Nephronophthisis,Kidney Angiomyolipoma,Aortic Disease,Skin Amelanotic Melanoma,Ovarian Cancer,Tuberous Sclerosis 2,Tuberous Sclerosis,Breast Cancer,Glioblastoma,Colorectal Cancer,Hepatocellular Carcinoma,Rhabdomyosarcoma,Acute Laryngopharyngitis,Gastric Cancer,Prostate Cancer,Disease Of Mental Health,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Diamond-Blackfan Anemia 20,Esophageal Cancer,Muscle Hypertrophy,Mantle Cell Lymphoma,Tuberous Sclerosis 1,Lymphangioleiomyomatosis,Leukodystrophy, Hypomyelinating, 12,Lung Cancer,Palmoplantar Keratoderma, Bothnian Type,Pancreatic Cancer |
3wf7_a | P23443 | ENSG00000108443 | RPS6KB1 | 99.40 | 3.90E-18 | 4.90E-22 | 163.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CLK3 |
Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) |
2.7.12.1 | Homo sapiens | 6ft7_b | P49761 | ENSG00000179335 | CLK3 | 99.40 | 1.60E-17 | 2.10E-21 | 160.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | CDK16 PCTAIRE1 PCTK1 |
Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1) |
2.7.11.22 | Homo sapiens | 5g6v_a | Q00536 | ENSG00000102225 | CDK16 | 99.40 | 4.10E-17 | 5.00E-21 | 157.60 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | CAMK4 CAMK CAMK-GR CAMKIV |
Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) |
2.7.11.17 | Homo sapiens | Lung Large Cell Carcinoma,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Crouzon Syndrome With Acanthosis Nigricans,Systemic Lupus Erythematosus,Gingival Fibromatosis |
2w4o_a | Q16566 | ENSG00000152495 | CAMK4 | 99.50 | 1.00E-18 | 1.30E-22 | 172.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ROP5B ROP5 TGRH88_057710 |
ROP5B ROP5 TGRH88_057710 |
Toxoplasma gondii | 4lv5_a | F2YGR7 | 99.30 | 5.20E-17 | 6.30E-21 | 159.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | MYLK4 SGK085 |
Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085) |
2.7.11.1 | Homo sapiens | Cardiomyopathy, Familial Restrictive, 2,Deafness, Autosomal Recessive 17,Deafness, Autosomal Recessive 14,Cardiomyopathy, Familial Restrictive, 3 |
2x4f_a | Q86YV6 | ENSG00000145949 | MYLK4 | 99.50 | 1.60E-18 | 1.90E-22 | 171.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ROCK2 KIAA0619 |
Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) |
2.7.11.1 | Homo sapiens | Coronary Artery Vasospasm,Dextrocardia,Ureteral Obstruction,Breast Cancer,Tongue Squamous Cell Carcinoma,Hypertension, Essential |
4wot_b | O75116 | ENSG00000134318 | ROCK2 | 99.40 | 4.50E-18 | 5.40E-22 | 170.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | PKMYT1 MYT1 |
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase) |
2.7.11.1 | Homo sapiens | 5vcy_a | Q99640 | ENSG00000127564 | PKMYT1 | 99.50 | 6.40E-19 | 8.10E-23 | 166.70 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | FES FPS |
Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) |
2.7.10.2 | Homo sapiens | Melanoma,Leukemia, Chronic Myeloid,Latent Syphilis,Sjogren-Larsson Syndrome,Leukemia,Myeloid Leukemia,Sarcoma,Ewing Sarcoma Of Bone,Neurofibrosarcoma,Acute Promyelocytic Leukemia,Miller-Dieker Lissencephaly Syndrome,Myopathy, Centronuclear, 2 |
3cbl_a | P07332 | ENSG00000182511 | FES | 99.40 | 4.20E-17 | 5.40E-21 | 157.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDC42BPB KIAA1124 |
Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) |
2.7.11.1 | Homo sapiens | Myotonic Dystrophy,Epidermolysis Bullosa Simplex, Dowling-Meara Type |
5ote_a | Q9Y5S2 | ENSG00000198752 | CDC42BPB | 99.50 | 1.00E-18 | 1.20E-22 | 175.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | ACK2 |
Casein kinase II subunit alpha (EC 2.7.11.1) (CK II) (CK2-alpha) |
2.7.11.1 | Zea mays | 4dgn_a | P28523 | 99.40 | 5.20E-18 | 6.60E-22 | 161.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | DAPK1 DAPK |
Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Squamous Cell Carcinoma,Childhood Acute Lymphocytic Leukemia,Lung Cancer Susceptibility 3,Adenoid Cystic Carcinoma,Cholecystitis,Alzheimer Disease,B-Cell Lymphoma,Mixed Oligodendroglioma-Astrocytoma,Transitional Cell Carcinoma,Bladder Cancer,Tuberous Sclerosis 2,Parkinson Disease, Late-Onset,Colorectal Cancer,Pediatric Lymphoma,Oligodendroglioma,Central Neurocytoma,Ischemia,Gastric Cancer,Pancreatic Ductal Adenocarcinoma,Cholangiocarcinoma,Cervical Cancer,Cervical Squamous Cell Carcinoma,Myelodysplastic Syndrome,Nasopharyngeal Carcinoma,Lung Cancer |
2w4k_a | P53355 | ENSG00000196730 | DAPK1 | 99.40 | 9.00E-18 | 1.10E-21 | 158.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | DMPK DM1PK MDPK |
Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) |
2.7.11.1 | Homo sapiens | Muscular Disease,Fuchs' Endothelial Dystrophy,Myopathy,Muscle Tissue Disease,Neuromuscular Disease,Hypertrophic Cardiomyopathy,Myotonic Disease,Myotonic Dystrophy 1,Muscular Dystrophy,Myotonic Dystrophy,Spinocerebellar Ataxia 8,Myotonic Cataract,Cataract,Oculopharyngeal Muscular Dystrophy,Hair Follicle Neoplasm,Myotonic Dystrophy 2,Myotonia,Immature Cataract,Lens Disease,Autosomal Dominant Cerebellar Ataxia,Disease Of Mental Health,Fragile X Syndrome,Huntington Disease-Like 2,First-Degree Atrioventricular Block,Fragile X-Associated Tremor/Ataxia Syndrome,X-Linked Hereditary Ataxia,Spinal And Bulbar Muscular Atrophy, X-Linked 1,Catecholaminergic Polymorphic Ventricular Tachycardia,Frontotemporal Dementia,3-Methylglutaconic Aciduria, Type Iii |
2vd5_a | Q09013 | ENSG00000104936 | DMPK | 99.40 | 9.50E-18 | 1.20E-21 | 166.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | Camk1 |
Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) |
2.7.11.17 | Rattus norvegicus | 1a06_a | Q63450 | 99.80 | 7.40E-25 | 7.90E-29 | 221.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | SRK2I 41K OSKL2 SNRK2.3 At5g66880 MUD21.14 |
Serine/threonine-protein kinase SRK2I (EC 2.7.11.1) (OST1-kinase-like 2) (Protein ATHPROKIN B) (SNF1-related kinase 2.3) (SnRK2.3) |
2.7.11.1 | Arabidopsis thaliana | 3uc3_a | Q39193 | 99.40 | 3.20E-17 | 4.00E-21 | 159.80 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | DCLK1 DCAMKL1 DCDC3A KIAA0369 |
Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1) |
2.7.11.1 | Homo sapiens | Zellweger Syndrome,Colorectal Cancer,Attention Deficit-Hyperactivity Disorder,Chemical Colitis,Band Heterotopia |
5jzn_a | O15075 | ENSG00000133083 | DCLK1 | 99.40 | 4.10E-17 | 5.30E-21 | 149.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | DYRK2 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) |
2.7.12.1 | Homo sapiens | 4azf_a | Q92630 | ENSG00000127334 | DYRK2 | 99.50 | 1.70E-18 | 2.00E-22 | 174.90 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YNL183C | NPR1 | SGDID:S000005127 | MAP4K4 HGK KIAA0687 NIK |
Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase) |
2.7.11.1 | Homo sapiens | Arteriovenous Malformations Of The Brain,Autosomal Recessive Distal Hereditary Motor Neuronopathy,Spinal Muscular Atrophy, Distal, Autosomal Recessive, 1,Theileriasis |
4u3y_a | O95819 | ENSG00000071054 | MAP4K4 | 99.30 | 1.00E-16 | 1.30E-20 | 153.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | Taok2 Tao2 |
Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) |
2.7.11.1 | Rattus norvegicus | 1u5r_b | Q9JLS3 | 99.40 | 5.90E-18 | 7.10E-22 | 166.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | CSNK2A2 CK2A2 |
Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Connective Tissue Disease,Neonatal Leukemia,Distal Muscular Dystrophy With Anterior Tibial Onset,Spermatogenic Failure 50,Breast Adenocarcinoma,Theileriasis,Spermatogenic Failure 9 |
6hmq_a | P19784 | ENSG00000070770 | CSNK2A2 | 99.50 | 8.20E-19 | 1.00E-22 | 172.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK) |
2.7.12.2 | Homo sapiens | Melanoma,Breast Mucoepidermoid Carcinoma,Anthrax Disease,Neuroblastoma,Hereditary Spastic Paraplegia,Ureteral Obstruction,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Prostate Cancer,Ovarian Serous Carcinoma,Cardiomyopathy, Familial Hypertrophic, 25,Lung Cancer,Pancreatic Cancer |
3aln_a | P45985 | ENSG00000065559 | MAP2K4 | 99.40 | 1.50E-17 | 1.90E-21 | 158.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | pknB Rv0014c MTCY10H4.14c |
Serine/threonine-protein kinase PknB (EC 2.7.11.1) |
2.7.11.1 | Mycobacterium tuberculosis | 6i2p_a | P9WI81 | 99.30 | 6.70E-17 | 9.00E-21 | 146.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | CAMK2D CAMKD |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) |
2.7.11.17 | Homo sapiens | Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1dd |
2vn9_a | Q13557 | ENSG00000145349 | CAMK2D | 99.30 | 9.80E-17 | 1.20E-20 | 151.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | RPS6KA1 MAPKAPK1A RSK1 |
Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) |
2.7.11.1 | Homo sapiens | Tuberous Sclerosis 2,Tuberous Sclerosis,Cardiomyopathy, Familial Hypertrophic, 4,Disease Of Mental Health,Adrenal Cortical Adenocarcinoma,Dyskeratosis Congenita, Autosomal Dominant 3,Tuberous Sclerosis 1,Coffin-Lowry Syndrome,Polycystic Kidney Disease 3 With Or Without Polycystic Liver Disease |
4nif_d | Q15418 | ENSG00000117676 | RPS6KA1 | 99.50 | 2.80E-18 | 3.40E-22 | 166.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | LDBPK_331470 |
LDBPK_331470 |
Leishmania donovani | 4qny_a | E9BQ78 | 99.30 | 9.40E-17 | 1.20E-20 | 155.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YNL183C | NPR1 | SGDID:S000005127 | Camk2d Kiaa4163 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) |
2.7.11.17 | Mus musculus | 6bab_a | Q6PHZ2 | 99.30 | 9.90E-17 | 1.20E-20 | 151.60 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | unc-43 K11E8.1 |
Calcium/calmodulin-dependent protein kinase type II (CaM kinase II) (EC 2.7.11.17) (Uncoordinated protein 43) |
2.7.11.17 | Caenorhabditis elegans | 2bdw_b | O62305 | 99.40 | 1.60E-17 | 2.00E-21 | 163.30 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YNL183C | NPR1 | SGDID:S000005127 | SRPK1 |
SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) |
2.7.11.1 | Homo sapiens | Denys-Drash Syndrome,Lung Cancer |
5my8_a | Q96SB4 | ENSG00000096063 | SRPK1 | 99.30 | 8.70E-17 | 1.10E-20 | 158.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CDK1 CDC2 CDC28A CDKN1 P34CDC2 |
Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) |
2.7.11.22,2.7.11.23, | Homo sapiens | Bartholin'S Gland Adenocarcinoma,Bone Cancer,Polyploidy,Alzheimer Disease,Retinal Cancer,Neuroblastoma,Leukemia, Acute Myeloid,Hereditary Spastic Paraplegia,Leukemia, Acute Lymphoblastic,Bladder Cancer,Brain Cancer,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Hepatocellular Carcinoma,Western Equine Encephalitis,Rhabdomyosarcoma,Fanconi Anemia, Complementation Group A,Neuronal Ceroid Lipofuscinosis,Breast Adenocarcinoma,Prostate Cancer,Cervical Cancer,Retinoblastoma,Lymphoma, Non-Hodgkin, Familial,Esophageal Cancer,Seckel Syndrome,Trichothiodystrophy 5, Nonphotosensitive,Mantle Cell Lymphoma,Gastrointestinal Stromal Tumor,Acute Promyelocytic Leukemia,Leukemia, Chronic Lymphocytic,Ceroid Lipofuscinosis, Neuronal, 2,Bloom Syndrome,Primary Autosomal Recessive Microcephaly,Ceroid Lipofuscinosis, Neuronal, 1,Lung Cancer,Frontotemporal Dementia |
4yc3_a | P06493 | ENSG00000170312 | CDK1 | 99.40 | 3.40E-17 | 4.40E-21 | 153.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | CAMK2A CAMKA KIAA0968 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17) |
2.7.11.17 | Homo sapiens | Kagami-Ogata Syndrome,Alzheimer Disease,Alacrima, Achalasia, And Mental Retardation Syndrome,Mental Retardation, Autosomal Dominant 53,Disease Of Mental Health,Mental Retardation, Autosomal Recessive 63,Attention Deficit-Hyperactivity Disorder,Autosomal Dominant Non-Syndromic Intellectual Disability,Rett Syndrome,Autism |
2vz6_b | Q9UQM7 | ENSG00000070808 | CAMK2A | 99.30 | 1.10E-16 | 1.40E-20 | 152.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MARK3 CTAK1 EMK2 |
MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) |
2.7.11.1 | Homo sapiens | Focal Epithelial Hyperplasia,Osteoporosis,Peutz-Jeghers Syndrome,Gaucher Disease, Type Iii,Visual Impairment And Progressive Phthisis Bulbi |
2qnj_b | P27448 | ENSG00000075413 | MARK3 | 99.40 | 2.40E-17 | 3.00E-21 | 157.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | MAP2K6 MEK6 MKK6 PRKMK6 SKK3 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) |
2.7.12.2 | Homo sapiens | Human Cytomegalovirus Infection,Anthrax Disease,Cardiomyopathy, Familial Hypertrophic, 25 |
3fme_a | P52564 | ENSG00000108984 | MAP2K6 | 99.30 | 5.50E-17 | 7.30E-21 | 148.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YNL183C | NPR1 | SGDID:S000005127 | Rop2 |
Rop2 |
Toxoplasma gondii | 3dzo_a | Q06AK3 | 99.40 | 8.10E-18 | 9.70E-22 | 169.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |